Etanercept (Enbrel(®)) alternative storage at ambient temperature

BACKGROUND: Biologic disease-modifying antirheumatic drugs, including tumor necrosis factor inhibitors such as etanercept (Enbrel(®)), have improved outcomes for patients with rheumatic and other inflammatory diseases, with sustained remission being the optimal goal for patients with rheumatoid arth...

Descripción completa

Detalles Bibliográficos
Autores principales: Shannon, Edel, Daffy, Joanne, Jones, Heather, Paulson, Andrea, Vicik, Steven M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531722/
https://www.ncbi.nlm.nih.gov/pubmed/28790869
http://dx.doi.org/10.2147/CPAA.S131832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531722/
https://www.ncbi.nlm.nih.gov/pubmed/28790869
http://dx.doi.org/10.2147/CPAA.S131832

Ejemplares similares